Drugs
-
Deferasirox (marketed as Exjade) Information
-
Related Information
Early Communication about an Ongoing Safety Review of Deferasirox (marketed as Exjade)
Updated 1/2/2010Exjade (deferasirox): Boxed Warning
MedWatch 1/28/2010
-
-
Labeling and Regulatory History from Drugs@FDA
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-